Nortem BioGroup (MLBIO) Stock Overview

Manufactures and markets natural products based on organic and biodegradable substances in Italy. More details

MLBIO fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Does not have a meaningful market cap (€14M)

MLBIO Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

Nortem BioGroup Competitors

Price History & Performance

Summary of share price highs, lows and changes for Nortem BioGroup
Historical stock prices
Current Share Price	€5.40
52 Week High	€0
52 Week Low	€0
Beta	0
1 Month Change	0%
3 Month Change	0%
1 Year Change	0%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	0%

Recent updates

Shareholder Returns

	MLBIO	FR Personal Products	FR Market
7D	0%	3.7%	0.8%
1Y	0%	1.1%	1.6%

Return vs Industry: MLBIO underperformed the French Personal Products industry which returned 1.1% over the past year.

Return vs Market: MLBIO underperformed the French Market which returned 1.6% over the past year.

Price Volatility

Is MLBIO's price volatile compared to industry and market?
MLBIO volatility
MLBIO Average Weekly Movement	0%
Personal Products Industry Average Movement	4.2%
Market Average Movement	5.2%
10% most volatile stocks in FR Market	11.0%
10% least volatile stocks in FR Market	2.7%

Stable Share Price: Data is not available.

Volatility Over Time: Insufficient data to determine MLBIO's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2002	n/a	n/a	nortembiogroup.com

Nortem BioGroup manufactures and markets natural products based on organic and biodegradable substances in Italy. The company provides food grade citric acid and sodium bicarbonate; Epson and Himalayan salt; spices, such as organic turmeric, ginger, and black pepper powder; and organic cocoa powder. It also offers vitamins, such as omega 3 and vitamin E food supplements, vitamin B12 food supplements, zinc and magnesium food supplements, vitamin D3 and K2 food supplements, vitamin C (ascorbic acid) powder, vitamin C (sodium ascorbate) powder, and N-acetyl cysteine food supplements.

Nortem BioGroup Fundamentals Summary

How do Nortem BioGroup's earnings and revenue compare to its market cap?
MLBIO fundamental statistics
Market cap	€13.92m
Earnings (TTM)	€0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is MLBIO overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MLBIO income statement (TTM)
Revenue	€0
Cost of Revenue	€0
Gross Profit	€0
Other Expenses	€0
Earnings	€0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did MLBIO perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/11 02:53
End of Day Share Price	2026/06/11 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Nortem BioGroup is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Nortem BioGroupENXTPA:MLBIO Stock Report